FR2390962A1 - Composition de depot pharmaceutique comprenant un polymere de p-dioxanone absorbable - Google Patents

Composition de depot pharmaceutique comprenant un polymere de p-dioxanone absorbable

Info

Publication number
FR2390962A1
FR2390962A1 FR7814975A FR7814975A FR2390962A1 FR 2390962 A1 FR2390962 A1 FR 2390962A1 FR 7814975 A FR7814975 A FR 7814975A FR 7814975 A FR7814975 A FR 7814975A FR 2390962 A1 FR2390962 A1 FR 2390962A1
Authority
FR
France
Prior art keywords
composition
absorbable
polymer
deposit containing
dioxanone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7814975A
Other languages
English (en)
Other versions
FR2390962B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethicon Inc
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of FR2390962A1 publication Critical patent/FR2390962A1/fr
Application granted granted Critical
Publication of FR2390962B1 publication Critical patent/FR2390962B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Abstract

L'invention concerne une composition de dépôt pharmaceutique pour une administration parentérale de quantités efficaces d'un médicament libéré lentement sur une période étendue de temps, et qui comprend une combinaison de 1 % à 99 % en poids d'une composition d'un médicament en une quantité de dépôt efficace supérieure à la seule dose unitaire; et un polymère solide et absorbable qui ne réagit pas vis-à-vis des tissus corporels et qui subit une biodégradation en présence des fluides corporels, en produits qui sont métabolisés ou évacués par le corps sans réaction adverse du corps. Selon l'invention, on emploie, comme polymère absorbable, un polymère de p-dioxanone ayant pour formule :
FR7814975A 1977-05-20 1978-05-19 Composition de depot pharmaceutique comprenant un polymere de p-dioxanone absorbable Granted FR2390962A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79904677A 1977-05-20 1977-05-20

Publications (2)

Publication Number Publication Date
FR2390962A1 true FR2390962A1 (fr) 1978-12-15
FR2390962B1 FR2390962B1 (fr) 1981-07-24

Family

ID=25174908

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7814975A Granted FR2390962A1 (fr) 1977-05-20 1978-05-19 Composition de depot pharmaceutique comprenant un polymere de p-dioxanone absorbable

Country Status (7)

Country Link
JP (1) JPS53145905A (fr)
AU (1) AU517229B2 (fr)
CA (1) CA1098443A (fr)
DE (1) DE2821949A1 (fr)
FR (1) FR2390962A1 (fr)
GB (1) GB1573459A (fr)
ZA (1) ZA782880B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0275961A2 (fr) * 1987-01-21 1988-07-27 Boehringer Ingelheim Kg Préparation médicale orale à libération prolongée
EP0635272A1 (fr) * 1993-07-20 1995-01-25 Ethicon Inc. Copolymères absorbables liquides pour applications parenterales

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
GB8403361D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical composition
GB8403360D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
US4643191A (en) * 1985-11-29 1987-02-17 Ethicon, Inc. Crystalline copolymers of p-dioxanone and lactide and surgical devices made therefrom
GB8805286D0 (en) * 1988-03-05 1988-04-07 Schering Agrochemicals Ltd Trypanocides
GB2361928A (en) * 2000-05-03 2001-11-07 Procter & Gamble Elastic packaging or binder material
EP1883665B1 (fr) 2005-04-22 2017-10-11 Universite De Geneve Compositions de polylactide and leurs utilisations
KR101501217B1 (ko) * 2014-07-17 2015-03-10 최명 필러용 폴리디옥사논 입자의 제조방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3190858A (en) * 1959-12-03 1965-06-22 Union Carbide Corp Polymerization of cyclic esters

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3190858A (en) * 1959-12-03 1965-06-22 Union Carbide Corp Polymerization of cyclic esters

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0275961A2 (fr) * 1987-01-21 1988-07-27 Boehringer Ingelheim Kg Préparation médicale orale à libération prolongée
DE3701625A1 (de) * 1987-01-21 1988-08-04 Boehringer Ingelheim Kg Perorale arzneimittelzubereitung mit verzoegerter wirkstofffreigabe
EP0275961A3 (en) * 1987-01-21 1990-11-22 Boehringer Ingelheim Kg Oral medical preparation with subtained release
EP0635272A1 (fr) * 1993-07-20 1995-01-25 Ethicon Inc. Copolymères absorbables liquides pour applications parenterales
US5631015A (en) * 1993-07-20 1997-05-20 Ethicon, Inc. Liquid absorbable copolymers for parenteral applications
US5653992A (en) * 1993-07-20 1997-08-05 Ethicon, Inc. Liquid absorbable copolymers for parenteral applications

Also Published As

Publication number Publication date
CA1098443A (fr) 1981-03-31
FR2390962B1 (fr) 1981-07-24
AU3560978A (en) 1979-11-08
DE2821949A1 (de) 1978-11-23
ZA782880B (en) 1980-01-30
JPS53145905A (en) 1978-12-19
AU517229B2 (en) 1981-07-16
GB1573459A (en) 1980-08-20

Similar Documents

Publication Publication Date Title
FR2404435A1 (fr) Compositions pharmaceutiques absorbables a base de copolyoxalates isomorphes
FR2404436A1 (fr) Compositions pharmaceutiques absorbables a base de poly (alcoylene oxalates)
CA2102454A1 (fr) Derives de l'erythromycine, leur procede de preparation, leur application comme medicaments
FR2390962A1 (fr) Composition de depot pharmaceutique comprenant un polymere de p-dioxanone absorbable
FR2382893A1 (fr) Composition pharmaceutique a base de cholestyramine
FR2603037A1 (fr) (pentamethyl-1,2,2,6,6,6 piperidyl-4 amino)- triazines, leur application comme stabilisants de matieres organiques, et compositions qui en contiennent
EP0145739A1 (fr) Nouveaux agents antiviraux.
ES482357A1 (es) Procedimiento para preparar compuestos prostanoides.
JPS55111499A (en) Glucosamine derivative and its preparation
TNSN91049A1 (fr) Benzimidazoles substitues, procedes en vue de leur preparation, et leur emploi pharmaceutique
AU608228B2 (en) Compositions for preventing graft rejection
GB1536515A (en) Compositions containing silicon derivatives
EP0176118A3 (fr) Oligosaccharides contenant des unités galactopyranose pour usage thérapeutique ou diagnostique, procédé et intermédiaires pour leur préparation
KR930700502A (ko) 6-아미노옥타히드로인돌리진트리올 유도체
EP0378825A3 (fr) Esters alicycliques et leur utilisation à titre d'ingrédients parfumants
GB1442640A (en) Anti-inflammatory polymers
ES480041A1 (es) Procedimiento para preparar acido ciclohexilcarboxilico y sus derivados.
OA08972A (fr) Nouveaux dérivés N-(vinblastinoyl-23) d'acide amino-1 méthylphosphonique, leursprocédés de préparation et les compositions pharmaceutiques qui les contiennent
FR2429229A1 (fr) Procede pour preparer des polyolefines
BE893957A (fr) Steroides esterifies en la position 17 et thio-esterifies en la position 21,leur procede de preparation et leur application comme medicament.
Thomas et al. Modulation of cellular and humoral immune responses by O, S, S-trimethyl phosphorodithioate, an impurity of commercial malathion
DK56687D0 (da) 5-substitueret octahydroindolizinforbindelser samt 7-ketomellemprodukter ved fremstillingen heraf
KR880013896A (ko) 벤조푸로[3,2-c]퀴놀린 화합물
KR880009644A (ko) 궤양성 대장질환 치료용 약한 조성물
GB1446726A (en) Aliphatically substituted aryl-chalcogeno-hydrocarbon derivative

Legal Events

Date Code Title Description
ST Notification of lapse